Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

---

​

FORM 6-K

​

---

​

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

​

For the Month of May 2023

​

Commission File Number: 001-37710

​

---

​

HUTCHMED (CHINA) LIMITED

(Translation of registrant’s name into English)

​

---

​

48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong

(Address of principal executive offices)

​

---

​

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

​

Form 20-F  ⌧             Form 40-F  ◻

​

​

​

​

---

​

HUTCHMED (CHINA) LIMITED

​

Form 6-K

​

EXHIBIT INDEX

​

Exhibit No.		Description
​	​	​
Exhibit 99.1	​	Press release relating to presentations at the 2023 ASCO Annual Meeting
Exhibit 99.2	​	Press release relating to new drug application (NDA) for fruquintinib for treatment of previously treated metastatic colorectal cancer granted priority review

​

2

---

​

SIGNATURE

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​

​

​	HUTCHMED (CHINA) LIMITED
​	​	​
​	​	​
​	By:	/s/ Johnny Cheng
​	Name:	Johnny Cheng
​	Title:	Chief Financial Officer

​

​

Date: May 26, 2023

3

---